Cargando…
A Review of Genetic and Gene Therapy for Parkinson’s Disease
Parkinson’s disease (PD) is a syndrome with deterioration of neurons, with its onset starting in the ’20s, known as the young beginning of Parkinson’s to the late inception of the ailment in the 60s. The majority of the environmental risk associated with PD is age. The pathophysiology of PD is relat...
Autores principales: | Dumbhare, Omkar, Gaurkar, Sagar S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991874/ https://www.ncbi.nlm.nih.gov/pubmed/36909056 http://dx.doi.org/10.7759/cureus.34657 |
Ejemplares similares
-
Neonatal Abstinence Syndrome: An Insight Over Impact of Maternal Substance Use
por: Dumbhare, Omkar, et al.
Publicado: (2023) -
Gene-wide significant association analyses of DNMT1 genetic variants with Parkinson’s disease
por: Wang, Jian-Yong, et al.
Publicado: (2023) -
Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson’s Disease
por: Helley, Martin P., et al.
Publicado: (2017) -
Identification of Immune-Related Hub Genes in Parkinson’s Disease
por: Chen, Lin, et al.
Publicado: (2022) -
Catecholaminergic Polymorphic Ventricular Tachycardia and Gene Therapy: A Comprehensive Review of the Literature
por: Henriquez, Elvis, et al.
Publicado: (2023)